Trials / Sponsors / Repertoire Immune Medicines
Repertoire Immune Medicines
Industry · 4 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | An Early Phase Trial of RPTR-1-201 in Advanced Solid Tumors Advanced Malignant Solid Tumor | Phase 1 / Phase 2 | 2025-12-12 |
| Terminated | RPTR-168 in Patients With Human Papillomavirus Strain 16 (HPV-16) E6/E7 Positive Tumors and Melanoma Head and Neck Squamous Cell Carcinoma, Melanoma, Cervical Cancer | Phase 1 | 2021-05-10 |
| Terminated | This SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Sele Head and Neck Cancer, Melanoma, HPV-Related Malignancy | — | 2021-05-05 |
| Terminated | RPTR-147 in Patients With Selected Solid Tumors and Lymphomas Solid Tumor, Lymphoma | Phase 1 | 2018-10-24 |